Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes

Plain-language summary

This study investigates cancer-susceptibility genes that may contribute to chordoma (a rare bone tumor). It included chordoma patients over age 6, living in the U.S. or Canada, who were the only person in their family diagnosed with chordoma. It was an observational (non-phase) study, ongoing but not currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Active, not recruiting

Sponsor

National Cancer Institute (NCI)

Start date

1/2/2011

Countries

United States

Related genes

Locations

• Rockville, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

* ELIGIBILITY CRITERIA:
* To be eligible subjects must be at least 6 years old at the time of enrollment, be the only person in their family ever diagnosed with chordoma, and reside in the U.S or Canada.
* Chordoma in the patients can have been diagnosed at any age and any primary site.